<DOC>
	<DOCNO>NCT03054766</DOCNO>
	<brief_summary>To investigate efficacy laser photocoagulation combine ranibizumab intravitreal injection macular edema ( ME ) secondary branch retinal vein occlusion ( BRVO ) long term .</brief_summary>
	<brief_title>Combination Intravitreal Ranibizumab With Without Macular Laser Photocoagulation ME Secondary BRVO</brief_title>
	<detailed_description>To investigate efficacy ranibizumab intravitreal injections-driven achieve vision acuity stabilization compare combination laser photocoagulation Chinese patient visual impairment ME due BRVO . The result trial use support new therapy BRVO China .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>1 . Written inform consent 2 . Male female Chinese patient ≥ 18 year age BRVO 3 . Visual impairment due ME secondary BRVO least one eye BCVA score 73 24 least 24 letter eye 1 . Pregnant nursing ( lactate ) woman woman childbearing potential without use effective contraception 2 . Stroke myocardial infarction le 3 month prior screen visit 3 . Renal failure creatinine level &gt; 2.0 mg/dl 4 . Uncontrolled hypertension 5 . Active ocular infection intraocular inflammation eye 6 . Neovascularization iris neovascular glaucoma eye 7 . History uveitis vitreomacular traction eye 8 . Treatment antiangiogenic drug within 3 month prior baseline visit eye 9 . Glaucoma intraocular pressure ( IOP ) ≥ 24 mmHg study eye 10 . Active proliferative diabetic retinopathy study eye 11 . Use investigational drug within 30 day systemic vascular endothecial growth factor ( VEGF ) antagonism drug within 6 month prior baseline visit 12 . Prior laser photocoagulation intraocular procedure within 3 month prior baseline study eye 13 . History intravitreal corticosteroid treatment phakic study eye , aphakic pseudophakic within 3 month prior screen 14 . History vitrectomy study eye 15 . Other protocol define inclusion /exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Laser Photocoagulation</keyword>
	<keyword>Ranibizumab</keyword>
	<keyword>Branch Retinal Vein Occlusion</keyword>
	<keyword>Vascular Endothecial Growth Factor</keyword>
</DOC>